Loading clinical trials...
Loading clinical trials...
Phase II Study on Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Conditions
Interventions
Pembrolizumab
Carboplatin
+1 more
Locations
1
Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy
Start Date
February 18, 2021
Primary Completion Date
September 1, 2023
Completion Date
September 1, 2023
Last Updated
August 27, 2021
NCT05975593
NCT07104149
NCT05378087
NCT05950087
NCT05311566
NCT06943833
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions